HOME >> BIOLOGY >> NEWS
The secret women keep from themselves

CHARLOTTESVILLE, VA (January 11, 2007) -- Do women have a secret so painful that they even keep it from themselves?

According to Dr. Anita H. Clayton of the University of Virginia Health System, the secret exists, and it's big. In an era when so many women are over-achievers with high expectations for almost every area of their lives, too many of them settle for mediocre sex.

Dr. Clayton, who is one of the world's preeminent experts on women's sexuality and a psychiatrist with the University of Virginia Health System, exposes and explores this secret in her new book, Satisfaction: Women, Sex, and the Quest for Intimacy, which is scheduled for release by Ballentine/Random House in mid-January.

Busy, overburdened lives often alter women's and men's libidos. Even when dissatisfied with their sexual lives, few women feel motivated to change, says Clayton.

"Work and family come first. We end up putting sex low on the priority list," Dr. Clayton notes. "Then when our partner initiates sex, it's just another task. I really believe that we as women accept a level of dissatisfaction that we don't need to accept."

Cultural and religious beliefs often place limitations on passion and desire, she adds. After pregnancy, a woman's view of herself as a sexual being may change. Menopause often considered a time of diminished desire can actually be a time of heightened arousal and desire because of more personal freedom and fewer childrearing responsibilities.

Written with Robin Cantor-Cooke, Satisfaction is based on Dr. Clayton's extensive research and clinical experience with thousands of women. The book provides guidance on a variety of topics, including:

  • Why drugs like Viagra, Levitra and Cialis don't work for women;
  • How the four main categories of female sexual dysfunction difficulty with desire, difficulty becoming aroused, difficulty achieving orgasm, and bodily pain during
    '"/>


Contact: Mary Jane Gore
mjgore@virginia.edu
434-924-9241
University of Virginia Health System
11-Jan-2007


Page: 1 2

Related biology news :

1. Secret life of elephant seals not secret anymore!
2. Anthrax bacteriums deadly secrets probed
3. Uncovering the secrets of the deep
4. Natures secrets yield new adhesive material
5. Decoding mushrooms secrets could combat carbon, find better biofuels and safer soils
6. St. Jude study yields secrets of chromosome movement
7. UVa-led team uncovers important secret in gene replication
8. UCR biologists unravel the genetic secrets of black widow spider silk
9. Nature surrenders flowery secrets to international team
10. Scientists identify prions infectious secret
11. Puzzling plankton yield secrets to role in evolution/global photosynthesis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The secret women keep from themselves

(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: